Patient Square Capital has successfully acquired Premier, Inc. for $2.6 billion, marking a significant investment in the technology-driven health care improvement sector.
About the Target: Premier, Inc.
Premier, Inc., headquartered in Charlotte, North Carolina, is a leading technology-driven health care improvement company recognized for uniting providers, suppliers, payers, and policymakers. Through its innovative services and solutions, Premier aims to enhance the quality of health care across the nation. The company offers integrated data and analytics, collaboratives, supply chain solutions, and consulting services to fulfill its mission of improving community health.
The company has recently been acquired by Patient Square Capital, with the deal valued at $2.6 billion. Following this acquisition, Premier's common stock has ceased trading and will be delisted from Nasdaq as of November 25, 2025. As part of the transaction, Premier stockholders will receive $28.25 in cash for each share they hold.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the United States
The health care industry in the United States is undergoing significant transformation, driven by technological advancements and increasing demands for efficient, patient-centric care. A growing focus on data analytics and integrated care
Similar Deals
Bambu Ventures → Lemonaid Health
2026
Heartland Dental → Smile Design Dentistry
2025
Sun Pharmaceutical Industries Limited → Checkpoint Therapeutics, Inc.
2025
Court Square Capital and WindRose Health Investors → Soleo Health
2025
Supernus Pharmaceuticals, Inc. → Sage Therapeutics, Inc.
2025
SERB Pharmaceuticals → Y-mAbs Therapeutics
2025
Patient Square Capital
invested in
Premier, Inc.
in 2025
in a Buyout deal
Disclosed details
Transaction Size: $2,600M